Elevated μ-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats

Journal of Neuroscience Research

Volumn 83, Issue 3, 2006, Pages 508-514

  Van Bockstaele, Elisabeth J ^a   Rudoy, C ^a   Mannelli, P ^a,b   Oropeza, V ^a   Qian, Y ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Locus coeruleus; Morphine; Norepinephrine; Western blot

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DRINKING WATER; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; NORADRENALIN; PROTEIN C FOS;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; FRONTAL CORTEX; LOCUS CERULEUS; LOW DRUG DOSE; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SOLITARY TRACT NUCLEUS; STATISTICAL SIGNIFICANCE; VENTRAL TEGMENTUM; WESTERN BLOTTING; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; GENE EXPRESSION; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SOLITARY NUCLEUS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 31844432772     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20738     Document Type: Article

References (82)

1. Aghajanian GK. 1978. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186-188.
2. Aghajanian GK, Kogan JH, Moghaddam B. 1994. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res 636:126-130.
3. Akaoka H, Aston-Jones G. 1991. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11:3830-3839.
4. Aston-Jones G, Hirata H, Akaoka H. 1997. Local opiate withdrawal in locus coeruleus in vivo. Brain Res 765:331-336.
5. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. 1999. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877:486-498.
6. Beckmann AM, Matsumoto I, Wilce PA. 1995. Immediate early gene expression during morphine withdrawal. Neuropharmacology 34:1183-1189.
7. Bergman SA, Wynn RL, Myers DE, Rudo FG. 1988. Low dose naloxone enhances buprenorphine in a tooth pulp antinociceptive assay. Arch Int Pharmacodyn Ther 291:229-237.
8. Bernstein MA, Welch SP. 1998. Mu-opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res 55:237-242.
9. Brady LS, Holtzman SG. 1981. Locomotor activity in morphine-dependent and post-dependent rats. Pharmacol Biochem Behav 14:361-370.
10. Buchsbaum MS, Davis GC, Bunney WE Jr. 1977. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 270:620-622.
11. Bullitt E. 1989. Induction of c-fos-like protein within the lumbar spinal cord and thalamus of the rat following peripheral stimulation. Brain Res 493:391-397.
12. Charney DS, Riordan CE, Kleber HD, Murburg M, Braverman P, Sternberg DE, Heninger GR, Redmond DE. 1982. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry 39:1327-1332.
13. Chieng B, Christie MJ. 1995. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci Lett 186:37-40.
14. Chieng B, Keay KA, Christie MJ. 1995. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci Lett 183:79-82.
15. Crain SM, Shen KF. 1995. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci USA 92:10540-10544.
16. Cucchia AT, Monnat M, Spagnoli J, Ferrero F, Bertschy G. 1998. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Drug Alcohol Depend 52:243-250.
17. De Giacomo M, Gaspari R, Stefanelli A, Barelli A, Mannelli P. 1999. Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone. Eur J Emerg Med 6:153-155.
18. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. 2000. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434.
19. Dossin O, Hanoun N, Zajac JM. 1996. Involvement of locus coeruleus projections in opiate withdrawal but not in opiate tolerance in mice. Eur J Pharmacol 308:271-274.
20. Duman RS, Tallman JF, Nestler EJ. 1988. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246:1033-1039.
21. Fan LW, Tanaka S, Tien LT, Ma T, Rockhold RW, Ho IK. 2002. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain. Brain Res Bull 58: 149-160.
22. Fan LW, Tien LT, Tanaka S, Ma T, Chudapongse N, Sinchaisuk S, Rockhold RW, Ho IK. 2003. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol. Neuroscience 121:1063-1074.
23. Funada M, Suzuki T, Sugano Y, Tsubai M, Misawa M, Ueda H, Misu Y. 1994. Role of beta-adrenoceptors in the expression of morphine withdrawal signs. Life Sci 54:L113-118.
24. Gellert VF, Sparber SB. 1977. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther 201:44-54.
25. Georges F, Stinus L, Le Moine C. 2000. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 12:4475-4486.
26. Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M. 1995. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 12:35-41.
27. Gillman MA, Lichtigfeld FJ. 1989. Analgesic nitrous oxide in neuropsychiatry: past, present and future. Int J Neurosci 49:75-81.
28. Gold LH, Stinus L, Inturrisi CE, Koob GF. 1994. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253:45-51.
29. Gold MS, Redmond DE, Kleber HD. 1978a. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 2:599-602.
30. Gold MS, Redmond DE, Kleber HD. 1978b. Clonidine in opiate withdrawal. Lancet 1:929-930.
31. Gold MS, Pottash AL, Sweeney DR, Kleber HD. 1980. Effect of methadone dosage on clonidine detoxification efficacy. Am J Psychiatry 137:375-376.
32. Gold MS, Pottash AC, Extein IL, Kleber HD. 1981. Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection. Prog Clin Biol Res 71:285-298.
33. Gracy KN, Dankiewicz LA, Koob GF. 2001. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24: 152-160.
34. Grant SJ, Huang YH, Redmond DE Jr. 1988. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation. Pharmacol Biochem Behav 30:13-19.
35. Guitart X, Nestler EJ. 1993. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus. Neurochem Res 18:5-13.
36. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ. 1992. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58:1168-1171.
37. Guitart X, Kogan JH, Berhow M, Terwilliger RZ, Aghajanian GK, Nestler EJ. 1993. Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals. Brain Res 611:7-17.
38. Hall W, Zador D. 2000. Challenge of reducing drug-related deaths. Lancet 356:7-8.
39. Harrison LM, Kastin AJ, Zadina JE. 1998. Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19:1603-1630.
40. Hayward MD, Duman RS, Nestler EJ. 1990. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res 525:256-266.
41. Higgins GA, Sellers EM. 1994. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav 48:1-8.
42. Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS. 2000. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem 74:199-208.
43. Javelle N, Renaud B, Lambas-Senas L. 1997. Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats. J Neurochem 68:683-690.
44. Kantak KM, Miczek KA. 1988. Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice. Psychopharmacology 96:468-476.
45. Kogan JH, Aghajanian GK. 1995. Long-term glutamate desensitization in locus coeruleus neurons and its role in opiate withdrawal. Brain Res 689:111-121.
46. Kogan JH, Nestler EJ, Aghajanian GK. 1992. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211:47-53.
47. Koob GF, Nestler EJ. 1997. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9:482-497.
48. Koob GF, Wall TL, Bloom FE. 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530-534.
49. Koob GF, Maldonado R, Stinus L. 1992. Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
50. Krystal JH, Compere S, Nestler EJ, Rasmussen K. 1996. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats. Physiol Behav 59: 863-866.
51. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ. 1997. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901.
52. Lasagna L. 1965. Drug interaction in the field of analgesic drugs. Proc R Soc Med 58:978-983.
53. Law PY, Loh HH. 1999. Regulation of opioid receptor activities. J Pharmacol Exp Ther 289:607-624.
54. Levine JD, Gordon NC. 1986. Method of administration determines the effect of naloxone on pain. Brain Res 365:377-378.
55. Levine JD, Gordon NC. 1988. Synergism between the analgesic actions of morphine and pentazocine. Pain 33:369-372.
56. Levine JD, Gordon NC, Bornstein JC, Fields HL. 1979a. Role of pain in placebo analgesia. Proc Natl Acad Sci U S A 76:3528-3531.
57. Levine JD, Gordon NC, Fields HL. 1979b. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 278: 740-741.
58. Levine JD, Gordon NC, Taiwo YO, Coderre TJ. 1988. Potentiation of pentazocine analgesia by low-dose naloxone. J Clin Invest 82:1574-1577.
59. Maldonado R. 1997. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104.
60. Maldonado R, Koob GF. 1993. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res 605:128-138.
61. Maldonado R, Valverde O, Garbay C, Roques BP. 1995. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol 352:565-575.
62. Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ. 2004. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. Biol Psychiatry 56:261-268.
63. Mulder AB, Hodenpijl MG, Lopes da Silva FH. 1998. Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci 18:5095-5102.
64. Nestler EJ. 2001. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
65. Nestler EJ, Erdos JJ, Terwilliger R, Duman RS, Tallman JF. 1989. Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res 476:230-239.
66. Nestler EJ, Alreja M, Aghajanian GK. 1994. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res Bull 35:521-528.
67. Powell KJ, Abul-Husn NS, Jhamandas A, Olmstead MC, Beninger RJ, Jhamandas K. 2002. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 300:588-596.
68. Rasmussen K. 1995. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology 13:295-300.
69. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ. 1990. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
70. Rasmussen K, Kendrick WT, Kogan JH, Aghajanian GK. 1996. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology 15:497-505.
71. Sagar SM, Sharp FR, Curran T. 1988. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328-1331.
72. Schaefer GJ, Michael RP. 1986. Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol Biochem Behav 25:1263-1269.
73. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF. 1994. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271:1391-1398.
74. Shen KF, Crain SM. 1997. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/ dependence in mice. Brain Res 757:176-190.
75. Stinus L, Le Moal M, Koob GF. 1990. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773.
76. Stornetta RL, Norton FE, Guyenet PG. 1993. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 624:19-28.
77. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond DE Jr. 1988. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96:121-134.
78. Taylor JR, Punch LJ, Elsworth JD. 1998. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology 138:133-142.
79. Tempel A, Gardner EL, Zukin RS. 1984. Visualization of opiate receptor upregulation by light microscopy autoradiography. Proc Natl Acad Sci U S A 81:3893-3897.
80. Ueda H, Miyamae T, Fukushima N, Misu Y. 1994. Protein kinase inhibitor potentiates opioid delta-receptor currents in Xenopus oocytes. Neuroreport 5:1985-1988.
81. Unterwald EM, Anton B, To T, Lam H, Evans CJ. 1998. Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone. Neuroscience 85:897-905.
82. Van Bockstaele EJ, Peoples J, Menko AS, McHugh K, Drolet G. 2000. Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment. J Neurosci 20:8659-8666.